Nucleic acid Isolation and Purification Market Worth 3,837.42 Million USD by 2020
PUNE, India, November 4, 2015 /PRNewswire/ --
According to a new market research report " Nucleic Acid Isolation and Purification Market by Product (Reagents, Kits, Instruments), Technology (Column-, Reagent-, Magnetic Bead-based), Application (Plasmid, Genomic DNA, miRNA, Total RNA, PCR Clean-up), & End Users - Global Forecast to 2020 ", published by MarketsandMarkets, The global Nucleic Acid Isolation and Purification Market is expected to reach USD 3,837.42 Million by 2020 from USD 2,560.31 Million in 2015, growing at a CAGR of 8.43% between 2015 and 2020.
Browse 80 market data Tables and 94 Figures spread through 169 Pages and in-depth TOC on "Nucleic Acid Isolation and Purification Market"
Early buyers will receive 10% customization on reports.
The report provides a detailed overview of the major drivers, restraints, and opportunities impacting the global Nucleic acid Isolation and Purification market along with the estimates and forecasts of the revenue and market share analysis.
The nucleic acid isolation and purification market exhibits lucrative growth potential from 2015 to 2020. This market is driven by factors such as increasing automation and technological advancements, availability of benchtop instruments, and increasing investments from pharma companies.
Increasing healthcare expenditure will aid the growth of the nucleic acid isolation and purification market. Today, healthcare expenditure constitutes a significant part of the development budget of all countries. It consists of spending by both public and private sources on medical goods and services. Rapid economic development across the globe is expected to improve access to quality healthcare. Increasing healthcare expenditure will lead to a rise in the demand for quality healthcare and will be an important growth driver for the nucleic acid isolation and purification market.
According to estimates from the World Bank, global healthcare spending increased at a CAGR of 6.97% from 2003 to 2013, from USD 3,786 Billion in 2003 to USD 7,427 Billion in 2013. In this period, public healthcare spending increased at a CAGR of 7.28%, from USD 2,198 Billion in 2003 to USD 4,440 Billion in 2013. This high growth rate, along with the substantial size of healthcare spending, will act as an important driver in the nucleic acid isolation and purification market.
The global nucleic acid isolation and purification market is segmented into products, technology, applications and end users. On the basis of product, the nucleic acid isolation and purification market is segmented into instruments, kits, and reagents. In 2015, the kits segment is expected to account for the largest share of the global nucleic acid isolation and purification market due to their low cost and easy usage in applications such as gene sequencing, molecular diagnostics, and gene cloning.
On the basis of technology, the nucleic acid isolation and purification market is segmented into column-based isolation and purification, reagent-based isolation and purification, magnetic bead-based isolation and purification, and other technologies. In 2015, the column-based isolation and purification segment is expected to account for the largest share of the global nucleic acid isolation and purification market. The technology is cost-effective, simpler, and faster when compared to organic extraction, and can also be automated.
Ask for PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=229978287
On the basis of application, the nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, blood DNA isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR clean-up and other applications. In 2015, the plasmid DNA isolation segment is expected to account for the largest share of the global market. Purified plasmid DNA is widely used in a variety of downstream applications such as PCR, sequencing, expression of proteins, gene therapy, and transfection.
On the basis of end user, the nucleic acid isolation and purification market is segmented into academic and government research institutes, pharmaceutical and biotechnology companies, contract research organizations, hospitals and diagnostic centers, and other end users. In 2015, the academic and government research institutes segment is expected to account for the largest share of the global nucleic acid isolation and purification market. This large share is attributed to the increasing research activities and use of nucleic acid test in molecular diagnostics.
On the basis of region, the nucleic acid isolation and purification market is segmented into Asia, Europe, North America, and the Rest of the World (RoW). In 2015, North America is expected to command the largest share of the global nucleic acid isolation and purification market.
The major players in the Nucleic Acid Isolation And Purification Market include QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (U.S.), Sigma-Aldrich Co. LLC (U.S.), Agilent Technologies Inc. (U.S.), Illumina, Inc. (U.S.), Takara Bio, Inc. (Japan), Promega Corporation (U.S.), General Electric Company (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), and Bio-Rad Laboratories (U.S.).
Browse Related Reports:
Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018
Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase) - Global Forecast to 2018
About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Share this article